caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871582239

Alice MatobaM.D.

OphthalmologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
171
Unique beneficiaries
—
Total services
350
Distinct HCPCS
5
Medicare payment
$39K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,238 Ophthalmology providers in TX — bottom quintile (cohort median 1,864).
REFERRAL NETWORK

Where Alice Matoba's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER63193
HARRIS COUNTY HOSPITAL DISTRICT45161
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
4077
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
3072
MORETTO, MATTHEW2263
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER1849
FIELDS, KATHLEEN1847
SELASSIE, RAHEL1647
BAYLOR COLLEGE OF MEDICINE AMBULATORY SURGERY CENTER1141
Patricia Chevez-Barrios
Pathology · Houston, TX
1137
BIEGEL, DIANE1134
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,177
Beneficiaries
—
Total drug cost
$76K
Distinct drugs
15
Brand share
35.3%
Top prescribed drugs
Moxifloxacin Hcl305 claims
Prednisolone Acetate182 claims
Fluorometholone149 claims
Loteprednol Etabonate128 claims
Gentamicin Sulfate92 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.